Theravance Biopharma Announces Modified Dutch Auction Tender Offer - Quick Facts

Theravance Biopharma, Inc. (TBPH) announced a modified Dutch auction tender offer to purchase up to $95 million of its ordinary shares, par value $0.00001 per share. The company is offering to purchase up to $95 million of its shares, at a purchase price not greater than $10.50 nor less than $9.75 per share, in cash, less any applicable withholding taxes and without interest. The offer will expire on November 10, 2022.

The modified Dutch auction tender offer allows shareholders to indicate how many shares and at what price or within the provided range they wish to tender their shares.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Vaccine partners Pfizer Inc. and BioNTech SE are seeking emergency use authorization or EUA from the U.S. Food and Drug Administration to offer their bivalent COVID-19 vaccine to children 6 months through 4 years of age. If authorized, the vaccine would be part of a primary series for children in this age group. Kraft Heinz Foods Co. is recalling around 2,400 pounds of ready-to-eat or RTE ham and cheese loaf products citing possible cross-contamination with under-processed products, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. Foxconn, Apple Inc.'s key iPhone assembler, expects that its major plant in China, which is being hit hard by worker unrest following Covid-19 spread and related restrictions, would restart full production around late December to early January, Reuters reported citing a Foxconn source.
Follow RTT